Skip to content
TrustList
Epidarex Capital logo
Venture capital firm

Epidarex Capital

Epidarex Capital

Write a review
Visit WebsiteGet introducedWrite a Review
Own this listing? Claim it
Epidarex Capital cover

About Epidarex Capital

We are trusted partners to our founders and co-investors We use our deep scientific and industry networks to create exceptional value and shared success Epidarex builds the extraordinary

Kynos Therapeutics Announces the Strengthening of its Board with the Appointment of Experienced Biotech Entrepreneur Jean Combalbert as Independent Chair

EDINBURGH, UK – Kynos Therapeutics Ltd, an immune-metabolic company with world-leading expertise in the kynurenine pathway and kynurenine 3-monooxygenase (KMO) biology, today announced

Dunad Therapeutics Appoints Michael Bonney as Chair of Board of Directors

Bonney brings over 30 years of life sciences industry leadership experience as company advances its covalent chemistry platform for targeted protein degradation and

Categories & features

Ask TrustList to introduce you to Epidarex Capital

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA — Google Privacy Policy and Terms apply.

Reviews

Write the first review of Epidarex Capital

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about Epidarex Capital.

Epidarex Capital alternatives

Similar listings buyers compare against this one.

Compare side by side
Keep exploring

More on TrustList

Everything here links back to the same verified catalogue. Pick your next stop.